Charcoal a weapon to fight superoxide-induced disease, injury Nanomaterials soak up radicals, could aid treatment of COVID-19

Charcoal a weapon to fight superoxide-induced disease, injury Nanomaterials soak up radicals, could aid treatment of COVID-19 HOUSTON – (July 1, 2020) – Artificial enzymes made of treated charcoal could have the power to curtail damaging levels of superoxides, radical oxygen ions that are toxic at high concentrations. The nanozymes developed by a Texas Medical Center team are highly effective antioxidants that break … Continue reading Charcoal a weapon to fight superoxide-induced disease, injury Nanomaterials soak up radicals, could aid treatment of COVID-19

Abnormal proteins in the gut could contribute to the development of Alzheimer’s Disease

Abnormal proteins in the gut could contribute to the development of Alzheimer’s Disease UNDER STRICT EMBARGO UNTIL 01.00 GMT DAY 3 JULY 2020  Not for publication or broadcast before this time  A new study published inThe Journal of Physiology has shown that misfolded protein build-up in the gut could contribute to the development of Alzheimer’s-like symptoms in mice. This … Continue reading Abnormal proteins in the gut could contribute to the development of Alzheimer’s Disease

malgamation of Takeda Canada Inc. and Shire Pharma Canada ULC Solidifies Company’s Leadership Position in Canadian Biopharmaceutical Industry

malgamation of Takeda Canada Inc. and Shire Pharma Canada ULC Solidifies Company’s Leadership Position in Canadian Biopharmaceutical Industry TORONTO, July 2, 2020 /CNW/ – Takeda Canada Inc. today announced the completion of the Canadian amalgamation with Shire Pharma Canada ULC, creating a portfolio of innovative treatments and establishing itself as a leader across several therapeutic areas. … Continue reading malgamation of Takeda Canada Inc. and Shire Pharma Canada ULC Solidifies Company’s Leadership Position in Canadian Biopharmaceutical Industry

St. Jude-WHO Virology Expert Comments on Flu Season in the Southern Hemisphere, Potential of New Pandemic, & Testing for both COVID & the Flu

St. Jude-WHO Virology Expert Comments on Flu Season in the Southern Hemisphere, Potential of New Pandemic, & Testing for both COVID & the Flu MEMPHIS, TENN. – As states see a spike in COVID positive cases, Dr. Richard Webby, a member of the Infectious Diseases Department at St. Jude Children’s Research Hospital and the World Health Organization’s Vaccine Composition … Continue reading St. Jude-WHO Virology Expert Comments on Flu Season in the Southern Hemisphere, Potential of New Pandemic, & Testing for both COVID & the Flu

Mitsubishi Tanabe Pharma Canada Announces that Manitoba has Added the Company’s Treatment for Amyotrophic Lateral Sclerosis (ALS) to its Provincial Drug Formulary

Mitsubishi Tanabe Pharma Canada Announces that Manitoba has Added the Company’s Treatment for Amyotrophic Lateral Sclerosis (ALS) to its Provincial Drug Formulary TORONTO, June 30, 2020 /CNW/ – Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), announced today that RADICAVA® (edaravone), an infusion treatment for amyotrophic lateral sclerosis (ALS), has … Continue reading Mitsubishi Tanabe Pharma Canada Announces that Manitoba has Added the Company’s Treatment for Amyotrophic Lateral Sclerosis (ALS) to its Provincial Drug Formulary